Skip to content

The effect of Application of “Truth Telling” protocol for medical diagnose declaring on treatment adherence and life expectancy in patent with Digestive cancer

The effect of Application of “Truth Telling” protocol for medical diagnose declaring on treatment adherence and life expectancy in patent with Digestive cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201027049165N1
Enrollment
70
Registered
2020-12-21
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer. C15-C26

Interventions

Intervention 1: Intervention group: For the research units that were in the Intervention group, at the first appropriate time when all the team members were present, the patient and his family went to

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Ability to understand and speak Persian Acceptable visual, auditory, and alert ability to answer questions With gastrointestinal cancer approved by a gastroenterologist and biopsy Age 40 to 70 years

Exclusion criteria

Exclusion criteria: Previous Cancer Awareness of your diagnosis upon arrival Having an important physical or mental illness (debilitating illness or being treated for mental illness) Having a debilitating complication hinders adherence to cancer treatment (including loss of consciousness, major mobility disorder, lack of family support)

Design outcomes

Primary

MeasureTime frame
Adherence score to treatment in Madanloo questionnaire. Timepoint: One week and one month after the intervention. Method of measurement: Madanlu Treatment Adherence Questionnaire.;Life expectancy score on the Miller questionnaire. Timepoint: Before the intervention and one month after the intervention. Method of measurement: Miller Life expectancy questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHasan Abbasi

Mashhad University of Medical Sciences

abbasih982@mums.ac.ir+98 51 3882 8299

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026